| Application | Recommended Dilution |
|---|---|
| IHC | 1:50-1:200 |
CCR3, also known as CD193, is a G protein-coupled receptor that plays a central role in eosinophil recruitment and allergic inflammatory responses. As the primary receptor for eotaxin chemokines, CCR3 mediates the selective migration of eosinophils to sites of inflammation, making it a critical target for researchers investigating asthma, allergic rhinitis, and other eosinophil-driven pathologies. Beyond its well-established role in allergy, CCR3 expression has been documented in various tissue contexts, expanding its relevance to broader immunological and oncological research.
This recombinant monoclonal antibody, clone 7F4, offers the reproducibility and consistency that demanding experimental workflows require. Generated against a synthetic peptide derived from human CCR3, the antibody is produced using recombinant technology, ensuring sequence-defined specificity and eliminating the lot-to-lot variability that can complicate longitudinal studies or multi-site collaborations. The rabbit IgG format provides excellent signal amplification when paired with standard secondary detection systems.
Validation studies demonstrate reliable performance in immunohistochemistry applications using paraffin-embedded human tissues. Testing in both normal human liver and liver cancer specimens at 1:100 dilution, with citrate buffer antigen retrieval and overnight primary incubation at 4°C, confirms the antibody's suitability for FFPE tissue analysis. The recommended working range of 1:50 to 1:200 provides flexibility for optimization across different tissue types and detection systems.
For immunology researchers exploring chemokine receptor biology, eosinophil trafficking mechanisms, or the tumor microenvironment, this CCR3 antibody delivers the technical reliability needed for confident data generation in both basic research and translational studies.
Email: support@cusabio.com
Distributors Worldwide